Signia Pure C&G BCT IX vs Sontro Soundwave

The Signia Pure C&G BCT IX is a premium behind-the-ear prescription hearing aid released in 2025, earning an A grade with a SoundScore of 4.4/5 in our lab testing. Priced at $3,398, it ranks #16 among 39 prescription hearing aids tested. In our standardized testing, this device demonstrates particular strength in own-voice comfort, scoring 3.8/5—a solid result that sits 1.10 points above the category average. This makes it a noteworthy option for users who prioritize natural sound quality when speaking. Speech clarity also performs well, with speech-in-quiet at 3.8/5 (+0.39 points above average) and speech-in-noise at 2.5/5 (+0.43 points above average), though the latter remains mixed in absolute terms despite beating the category benchmark. Feedback handling presents an interesting picture: at 4.2/5, it's strong in absolute terms, though it falls 0.52 points below the category average of 4.72/5. Music streaming scores 2.7/5, essentially matching the category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. While the Pure C&G BCT IX delivers solid overall performance, shoppers in this premium price tier should note that competitors like the Phonak Sphere Infinio and Oticon Intent score higher in our testing. Budget-conscious buyers may also find comparable sound quality at lower price points from options like the Rexton Reach R-Li T80 at Costco. This hearing aid is best suited for users who value own-voice naturalness and reliable speech clarity in everyday listening situations.

The Sontro Soundwave is a mid-priced OTC hearing aid that earns a B grade with a SoundScore of 3.0/5 in our lab testing. At $849, this behind-the-ear device uses disposable batteries and sits in the lower tier of OTC performance, ranking #61 of 65 devices in its category. The Soundwave's strongest attribute is own-voice comfort, scoring 3.6/5—a solid result that sits 1.09 points above the OTC category average. This makes it relatively comfortable for wearers who are sensitive to hearing their own voice sound unnatural or boomy. However, other performance areas present significant limitations. Speech clarity scores are below average in both quiet and noisy environments. Speech in quiet scores 2.7/5 (0.12 points below average), while speech in noise drops to 1.2/5 (0.28 points below average). Feedback handling is a notable weakness at 2.5/5, falling 2.04 points below the category average of 4.54/5. Perhaps most limiting is the music streaming score of 0.0/5, indicating this device does not support phone audio streaming—a feature many competitors in this price range offer. Consumers prioritizing own-voice comfort on a moderate budget may find the Soundwave acceptable, but those seeking strong speech clarity or streaming capability should consider alternatives. Several higher-performing OTC devices are available at similar or lower price points, including options like the Lexie Lumen or HearingAssist Control that deliver comparable or better overall sound quality.